---
figid: PMC11651285__KCBT_A_2441499_F0001_OC
figtitle: 'First-line treatments for KRAS-mutant non-small cell lung cancer: current
  state and future perspectives'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11651285
filename: KCBT_A_2441499_F0001_OC.jpg
figlink: /pmc/articles/PMC11651285/figure/F1/
number: F1
caption: The KRAS signaling pathway
papertitle: 'First-line treatments for KRAS-mutant non-small cell lung cancer: current
  state and future perspectives'
reftext: Qi He, et al. Cancer Biol Ther. 2024 Dec 16;26(1).
year: '2024'
doi: 10.1080/15384047.2024.2441499
journal_title: Cancer Biology & Therapy
journal_nlm_ta: Cancer Biol Ther
publisher_name: Taylor & Francis
keywords: Kirsten rat sarcoma viral oncogene (KRAS) | first-line | immune checkpoint
  inhibitors (ICIs) | anti-vascular therapy | chemotherapy
automl_pathway: 0.9380562
figid_alias: PMC11651285__F1
figtype: Figure
redirect_from: /figures/PMC11651285__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11651285__KCBT_A_2441499_F0001_OC.html
  '@type': Dataset
  description: The KRAS signaling pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - EPHB2
  - MAPK1
  - MAPK3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - KRAS
  - HRAS
  - NRAS
  - PTPN11
  - RASA1
  - RGS6
  - XYLT2
  - SOS1
  - SOS2
  - GRB2
  - MTG1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - EGFR inhibitors
  - GDP
  - RAS
  - GAP
  - GTP
  - MEK
---
